TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ADPT

Adaptive Biotechnologies Corp

Healthcare · Diagnostics & Research

28.60$ +0.2% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement ADPT
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
+44.8% +52.8% +15.6% +56.9% +20.1% -8.1% +5.1% +54.8%
+25.4% +13.2% +1.1% +118.8% +17.5% +30.5% -4.6% -1.0%
+58.1% +74.5% +20.8% +38.5% +21.3% -25.6% +12.8% +92.4%
+22.4% +80.6% +64.2% +22.6% -0.4% -13.9% -15.7% -8.9%
+28.0% +48.6% +63.3% +50.4% +18.8% -5.2% -13.3% -0.1%
+29.1% +64.6% +62.0% +37.3% +4.3% -1.8% -16.3% -2.5%
+154.1% +225.6% -16.1% +1.7%
-395.7%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?